• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, May 16, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

A new strategy for the synthesis of complex natural products

Bioengineer by Bioengineer
October 9, 2019
in Chemistry
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: University of Basel, Olivier Baudoin with permission from G. Roberts


Chemists from the University of Basel have succeeded in synthesizing two complex natural products from the group of dithiodiketopiperazines (DTPs). For this, they employed a new strategy based on “C-H bond activation,” resulting in a short and high yielding route. In the most recent edition of the Journal of the American Chemical Society, the researchers describe their new concept for the total synthesis of Epicoccin G and Rostratin A.

Certain microorganisms, such as fungi, are a rich source of secondary metabolites, which have great potential in medicinal applications. Of particular interest among these secondary metabolites are the dithiodiketopiperazines (DTPs), as they possess a variety of interesting biological activities that could be used in the development of new drugs for malaria or cancer. However, despite extensive efforts over the past decade, relatively few total syntheses of these molecules have been completed and obtaining the necessary quantities for further investigation remains a challenging target.

Professor Olivier Baudoin and first author Pierre Thesmar from the Department of Chemistry at the University of Basel have now succeeded in the development of an efficient and scalable synthesis of two of these structurally challenging natural products.

C-H bond activation as a new synthetic strategy

The synthesis route used by the Basel team employed a new strategy for the ring system construction involving a method known as “C-H bond activation,” which in recent years has become a valuable synthetic tool. In this key step, two rings are simultaneously formed by a twofold reaction in which a carbon-hydrogen bond (C-H bond) is cleaved and a carbon-carbon bond (C-C bond) formed. This route allows efficient access to a common intermediate on multigram quantities from inexpensive, commercially available starting materials.

This intermediate was then converted to the first natural DTP, Epicoccin G, in seven additional steps. Compared with the previous single total synthesis of the same molecule, the current synthesis displays 14 steps instead of 17, and a much higher overall yield of 19.6% rather than 1.5%.

Next challenge: Rostratin A

Following the successful synthesis of Epicoccin G, the research team ventured to synthesize Rostratin A, a related natural DTP, for the first time and on a larger scale. This molecule displays a number of daunting structural elements that necessitated a significant adaptation of the synthesis end-game. After much experimentation, optimization of each step and validation on multigram quantities, Rostratin A was synthesized on a 500 mg scale. Overall, this total synthesis was completed in 17 steps and with a high overall yield of 12.7%.

The new strategy reveals the high potential of the C-H bond activation method in the field of natural product synthesis. In a next step, the researchers aim to synthesize other natural DTPs and their analogues in order to conduct more advanced studies and further evaluate the medicinal potential.

###

Further information

Prof. Dr. Olivier Baudoin, University of Basel, Department of Chemistry, phone +41 61 207 1198, email: [email protected]

Media Contact
Iris Mickein
[email protected]
41-612-072-425

Original Source

https://www.unibas.ch/en/News-Events/News/Uni-Research/A-new-strategy-for-the-synthesis-of-complex-natural-products.html

Related Journal Article

http://dx.doi.org/10.1021/jacs.9b09359

Tags: BiochemistryChemistry/Physics/Materials SciencesMedicine/Health
Share13Tweet8Share2ShareShareShare2

Related Posts

New Drexel Study Reveals Key to Keeping Students on Track in Physics Learning — Chemistry

New Drexel Study Reveals Key to Keeping Students on Track in Physics Learning

May 15, 2026
Reversible Glue Technology Powers Up with Electric Activation — Chemistry

Reversible Glue Technology Powers Up with Electric Activation

May 15, 2026

Sweet as Honey: Unveiling a New Heat Transport Regime in Ultrathin Semiconductors

May 15, 2026

High-Precision Boltzmann Luminescent Nanothermometry Achieved Through Predictive Rules

May 15, 2026
Please login to join discussion

POPULAR NEWS

  • Research Indicates Potential Connection Between Prenatal Medication Exposure and Elevated Autism Risk

    843 shares
    Share 337 Tweet 211
  • New Study Reveals Plants Can Detect the Sound of Rain

    730 shares
    Share 291 Tweet 182
  • Salmonella Haem Blocks Macrophages, Boosts Infection

    62 shares
    Share 25 Tweet 16
  • Breastmilk Balances E. coli and Beneficial Bacteria in Infant Gut Microbiomes

    58 shares
    Share 23 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Pembrolizumab and Lenvatinib Trial for Mucosal Melanoma

Carboplatin ± Nivolumab in Metastatic TNBC Trial

New Numeracy Screener Developed for Preschoolers

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.